How Brain Tumors Turn Immune Cells into Cancer-Growing Hostages
Researchers discover that brain cancer tumors reprogram immune cells to help them grow, rather than suppress them.
Researchers discover that brain cancer tumors reprogram immune cells to help them grow, rather than suppress them.
There is consistent, strong evidence that the SARS-CoV-2 virus, which causes COVID-19, is predominantly transmitted through the air, according to a new assessment published April 15 in the medical journal Lancet.
Moores Cancer Center at UC San Diego Health is among the few clinical trial sites in the U.S. for the Pancreatic Cancer Action Network’s (PanCAN) newly created Precision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer.
The UC San Diego Autism Center for Excellence has received a $1.5 million gift from Kristin Farmer, founder and chief executive officer of ACES, a company that provides services to children with autism and their families, to support the work of Karen Pierce, co-director of the Autism Center.
After successfully preventing outbreaks of COVID-19 through its nationally recognized Return to Learn program, the University of California San Diego has announced plans to have a campus nearly fully occupied for fall 2021.
UC San Diego researchers found that the chemical inhibitor K777 reduces the coronavirus’ ability to infect cell lines by blocking human enzyme cathepsin L; clinical trials are underway.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.